Xtandi

Xtandi (Enzalutamide) is an oral prescription medication used for certain types of prostate cancer. It belongs to a class of drugs known as antiandrogens, which block the effects of male hormones. This medication is taken by mouth and works by slowing the growth of cancer cells.

Xtandi (Enzalutamide) is primarily used to treat prostate cancer in men. It is prescribed for patients with metastatic castration-resistant prostate cancer (mCRPC) or metastatic hormone-sensitive prostate cancer (mHSPC). The medication helps slow disease progression by blocking androgen receptors, which are involved in prostate cancer growth. It may also be used in combination with other therapies as directed by a healthcare provider.

Xtandi (Enzalutamide) works by interfering with the action of male hormones, which can help reduce symptoms and slow the progression of prostate cancer. Common effects include fatigue, back pain, and hot flashes. Some patients may experience nausea or constipation. These effects vary by individual and should be discussed with a healthcare professional.

Xtandi (Enzalutamide) should be taken exactly as prescribed by a doctor. Patients should inform their healthcare provider about all medications, supplements, and medical conditions before starting treatment. It is important to attend regular follow-up appointments to monitor progress and manage any side effects. Avoid grapefruit products unless approved by a doctor.

Xtandi (Enzalutamide) may interact with other medications, including blood thinners, certain antibiotics, and herbal supplements. Strong CYP3A4 inhibitors or inducers can affect its levels in the body. Alcohol and grapefruit products may also interact, potentially altering effectiveness or side effects. Always consult a healthcare provider before combining medications.